Digital Pathology Market by Product (Scanner, Software, Storage Systems, Communication System), Type (Human, Veterinary), End User (Educational, Clinical, Pharma & Biotech Companies), Application (Teleconsultation, Disease Diagnosis, Drug Discovery, Training & Education) - Global Opportunity Analysis and Industry Forecast, 2020 - 2030

Abstract
Market Definition:

The Global Digital Pathology Market was valued at USD 4.96 billion in 2019 and is estimated to reach USD 17.28 billion by 2030, expanding at a CAGR of 11.9% during the forecast period from 2019 to 2030.

Digital pathology is also known as digital imaging, virtual slides, or virtual microscopy. It is a dynamic image-based environment that helps in the procurement, administration, and interpretation of pathological information using a computer. It helps pathologist observe slides under a microscope and digitize the images using an image analysis software. Digital pathology provides live and high resolution images that aid pathologist to diagnose better.

The adoption of digital pathology has increased in numerous applications such as diagnosis of diseases, research, and drug discovery. Also, the demand for digital pathology has increased due to the rising occurrence of chronic diseases around the world.

Market Dynamics and Trends

Rising prevalence of chronic diseases, increasing demand for the implementation of rapid diagnostic tools, and rising trend of digitization in the medical sector are driving the digital pathology market. Also, growing adoption of digital pathology for disease diagnosis, increasing government support, and ease of consultation have contributed to the growth of digital pathology market.

However, high cost and lack of reimbursements may hamper the digital pathology market. On the other hand, increasing awareness regarding the advantages of digital pathology, introduction of affordable scanners for private pathology practices, and increasing requirement for personalized medicine are creating new opportunities in the market.

Market Segmentations and Scope of the Study:

The global digital pathology market is segmented based on product, application, end user, and geography. On the basis of product, the market is segmented into scanners, software, and storage & communication systems. In terms of application, the market is segregated into teleconsultation, disease diagnosis, drug discovery, and training & education. Based on end user, the market is categorized as educational, clinical, and pharma & biotech companies. On the basis of region the market is classified as North America, Europe, Asia Pacific, and Rest of the World (RoW).

Geographical Analysis

North America accounts for the largest share of the market and this trend is projected to continue during the forecast period due to factors such as high adoption of digital pathology, increase in R&D investments, presence of major market players, and high consumer awareness. The market in Asia-Pacific is projected to expand owing to the improvements in healthcare facilities, increasing adoption of advanced imaging modalities, and penetration of multi-national companies in the region to harness the untapped potential.

Competitive Landscape

Key players in the global digital pathology market include 3DHISTECH Ltd., Danaher Corporation (Leica Microsystem), Glencoe Software, Inc., Hamamatsu Photonics K.K., Indica Labs Inc., Koninklijke Philips N.V., Nikon Corporation, PerkinElmer Inc., Roche (Ventana Medical Systems, Inc.), and Visiopharm A/S.

KEY MARKET SEGMENTS:
• Global Digital Pathology Market – By Product
- Scanners
- Software
- Storage & Communication Systems
• Global Digital Pathology Market – By Application
- Teleconsultation
- Disease Diagnosis
- Drug Discovery
- Training & Education
• Global Digital Pathology Market – By End User
- Educational
- Clinical
- Pharma & Biotech Companies
• Global Digital Pathology Market – By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- Spain
- France
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- RoW
- Brazil
- Saudi Arabia
- South Africa
- Remaining Countries

KEY PLAYERS:
• 3DHISTECH Ltd.
• Danaher Corporation (Leica Microsystem)
• Glencoe Software, Inc.
• Hamamatsu Photonics K.K.
• Indica Labs Inc.
• Koninklijke Philips N.V.
• Nikon Corporation
• PerkinElmer Inc.
• Roche (Ventana Medical Systems, Inc.)
• Visiopharm A/S.

Content
1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2. MARKET SNAPSHOT, 2019-2030 MILLION USD
2.1. MARKET SNAPSHOT
3. PORTER’S FIVE FORCE MODEL ANALYSIS
4. MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5. GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT
5.1. OVERVIEW
5.2. SCANNERS
5.2.1 SCANNERS MARKET, BY REGION
5.2.1.1 North America Scanners Market, By Country
5.2.1.2 Europe Scanners Market, By Country
5.2.1.3 Asia-Pacific Scanners Market, By Country
5.2.1.4 Rest of World Scanners Market, By Country
5.3. SOFTWARE
5.3.1 SOFTWARE MARKET, BY REGION
5.3.1.1 North America Software Market, By Country
5.3.1.2 Europe Software Market, By Country
5.3.1.3 Asia-Pacific Software Market, By Country
5.3.1.4 Rest of World Software Market, By Country
5.4. STORAGE AND COMMUNICATION SYSTEMS
5.4.1 STORAGE AND COMMUNICATION SYSTEMS MARKET, BY REGION
5.4.1.1 North America Storage and Communication Systems Market, By Country
5.4.1.2 Europe Storage and Communication Systems Market, By Country
5.4.1.3 Asia-Pacific Storage and Communication Systems Market, By Country
5.4.1.4 Rest of World Storage and Communication Systems Market, By Country
6. GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION
6.1. OVERVIEW
6.2. TELECONSULTATION
6.2.1 TELECONSULTATION MARKET, BY REGION
6.2.1.1 North America Teleconsultation Market, By Country
6.2.1.2 Europe Teleconsultation Market, By Country
6.2.1.3 Asia-Pacific Teleconsultation Market, By Country
6.2.1.4 Rest of World Teleconsultation Market, By Country
6.3. DISEASE DIAGNOSIS
6.3.1 DISEASE DIAGNOSIS MARKET, BY REGION
6.3.1.1 North America Disease Diagnosis Market, By Country
6.3.1.2 Europe Disease Diagnosis Market, By Country
6.3.1.3 Asia-Pacific Disease Diagnosis Market, By Country
6.3.1.4 Rest of World Disease Diagnosis Market, By Country
6.4. DRUG DISCOVERY
6.4.1 DRUG DISCOVERY MARKET, BY REGION
6.4.1.1 North America Drug Discovery Market, By Country
6.4.1.2 Europe Drug Discovery Market, By Country
6.4.1.3 Asia-Pacific Drug Discovery Market, By Country
6.4.1.4 Rest of World Drug Discovery Market, By Country
6.5. TRAINING & EDUCATION
6.5.1 TRAINING & EDUCATION MARKET, BY REGION
6.5.1.1 North America Training & Education Market, By Country
6.5.1.2 Europe Training & Education Market, By Country
6.5.1.3 Asia-Pacific Training & Education Market, By Country
6.5.1.4 Rest of World Training & Education Market, By Country
7. GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER
7.1. OVERVIEW
7.2. EDUCATIONAL
7.2.1 EDUCATIONAL MARKET, BY REGION
7.2.1.1 North America Educational Market, By Country
7.2.1.2 Europe Educational Market, By Country
7.2.1.3 Asia-Pacific Educational Market, By Country
7.2.1.4 Rest of World Educational Market, By Country
7.3. CLINICAL
7.3.1 CLINICAL MARKET, BY REGION
7.3.1.1 North America Clinical Market, By Country
7.3.1.2 Europe Clinical Market, By Country
7.3.1.3 Asia-Pacific Clinical Market, By Country
7.3.1.4 Rest of World Clinical Market, By Country
7.4.
7.4.1 PHARMA & BIOTECH COMPANIES MARKET, BY REGION
7.4.1.1 North America Pharma & Biotech Companies Market, By Country
7.4.1.2 Europe Pharma & Biotech Companies Market, By Country
7.4.1.3 Asia-Pacific Pharma & Biotech Companies Market, By Country
7.4.1.4 Rest of World Pharma & Biotech Companies Market, By Country
8. GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1 NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY PRODUCT
8.2.2 NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY APPLICATION
8.2.3 NORTH AMERICA DIGITAL PATHOLOGY MARKET, BY END USER
8.2.4 NORTH AMERICA DIGITAL PATHOLOGY, MARKET BY COUNTRY
8.2.4.1 U.S
8.2.4.1.1 U.S Digital Pathology Market, By Product
8.2.4.1.2 U.S Digital Pathology Market, By Application
8.2.4.1.3 U.S Digital Pathology Market, By End User
8.2.4.2 Canada
8.2.4.2.1 Canada Digital Pathology Market, By Product
8.2.4.2.2 Canada Digital Pathology Market, By Application
8.2.4.2.3 Canada Digital Pathology Market, By End User
8.2.4.3 Mexico
8.2.4.3.1 Mexico Digital Pathology Market, By Product
8.2.4.3.2 Mexico Digital Pathology Market, By Application
8.2.4.3.3 Mexico Digital Pathology Market, By End User
8.3. EUROPE
8.3.1 EUROPE DIGITAL PATHOLOGY MARKET, BY PRODUCT
8.3.2 EUROPE DIGITAL PATHOLOGY MARKET, BY APPLICATION
8.3.3 EUROPE DIGITAL PATHOLOGY MARKET, BY END USER
8.3.4 EUROPE DIGITAL PATHOLOGY, MARKET BY COUNTRY
8.3.4.1 UK
8.3.4.1.1 UK Digital Pathology Market, By Product
8.3.4.1.2 UK Digital Pathology Market, By Application
8.3.4.1.3 UK Digital Pathology Market, By End User
8.3.4.2 Germany
8.3.4.2.1 Germany Digital Pathology Market, By Product
8.3.4.2.2 Germany Digital Pathology Market, By Application
8.3.4.2.3 Germany Digital Pathology Market, By End User
8.3.4.3 France
8.3.4.3.1 France Digital Pathology Market, By Product
8.3.4.3.2 France Digital Pathology Market, By Application
8.3.4.3.3 France Digital Pathology Market, By End User
8.3.4.4 Italy
8.3.4.4.1 Italy Digital Pathology Market, By Product
8.3.4.4.2 Italy Digital Pathology Market, By Application
8.3.4.4.3 Italy Digital Pathology Market, By End User
8.3.4.5 Spain
8.3.4.5.1 Spain Digital Pathology Market, By Product
8.3.4.5.2 Spain Digital Pathology Market, By Application
8.3.4.5.3 Spain Digital Pathology Market, By End User
8.3.4.6 Rest of Europe
8.3.4.6.1 Rest of Europe Digital Pathology Market, By Product
8.3.4.6.2 Rest of Europe Digital Pathology Market, By Application
8.3.4.6.3 Rest of Europe Digital Pathology Market, By End User
8.4. ASIA-PACIFIC
8.4.1 ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY PRODUCT
8.4.2 ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY APPLICATION
8.4.3 ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, BY END USER
8.4.4 ASIA-PACIFIC DIGITAL PATHOLOGY, MARKET BY COUNTRY
8.4.4.1 China
8.4.4.1.1 China Digital Pathology Market, By Product
8.4.4.1.2 China Digital Pathology Market, By Application
8.4.4.1.3 China Digital Pathology Market, By End User
8.4.4.2 Japan
8.4.4.2.1 Japan Digital Pathology Market, By Product
8.4.4.2.2 Japan Digital Pathology Market, By Application
8.4.4.2.3 Japan Digital Pathology Market, By End User
8.4.4.3 India
8.4.4.3.1 India Digital Pathology Market, By Product
8.4.4.3.2 India Digital Pathology Market, By Application
8.4.4.3.3 India Digital Pathology Market, By End User
8.4.4.4 South Korea
8.4.4.4.1 South Korea Digital Pathology Market, By Product
8.4.4.4.2 South Korea Digital Pathology Market, By Application
8.4.4.4.3 South Korea Digital Pathology Market, By End User
8.4.4.5 Rest of Asia-Pacific
8.4.4.5.1 Rest of Asia-Pacific Digital Pathology Market, By Product
8.4.4.5.2 Rest of Asia-Pacific Digital Pathology Market, By Application
8.4.4.5.3 Rest of Asia-Pacific Digital Pathology Market, By End User
8.5. REST OF WORLD
8.5.1 REST OF WORLD DIGITAL PATHOLOGY MARKET, BY PRODUCT
8.5.2 REST OF WORLD DIGITAL PATHOLOGY MARKET, BY APPLICATION
8.5.3 REST OF WORLD DIGITAL PATHOLOGY MARKET, BY END USER
8.5.4 REST OF WORLD DIGITAL PATHOLOGY, MARKET BY COUNTRY
8.5.4.1 Brazil
8.5.4.1.1 Brazil Digital Pathology Market, By Product
8.5.4.1.2 Brazil Digital Pathology Market, By Application
8.5.4.1.3 Brazil Digital Pathology Market, By End User
8.5.4.2 Saudi Arabia
8.5.4.2.1 Saudi Arabia Digital Pathology Market, By Product
8.5.4.2.2 Saudi Arabia Digital Pathology Market, By Application
8.5.4.2.3 Saudi Arabia Digital Pathology Market, By End User
8.5.4.3 South Africa
8.5.4.3.1 South Africa Digital Pathology Market, By Product
8.5.4.3.2 South Africa Digital Pathology Market, By Application
8.5.4.3.3 South Africa Digital Pathology Market, By End User
8.5.4.4 Remaining Countries
8.5.4.4.1 Remaining Countries Digital Pathology Market, By Product
8.5.4.4.2 Remaining Countries Digital Pathology Market, By Application
8.5.4.4.3 Remaining Countries Digital Pathology Market, By End User
9. COMPANY PROFILES
9.1. DANAHER CORPORATION (LEICA MICROSYSTEM)
9.1.1 COMPANY OVERVIEW
9.1.2 COMPANY SNAPSHOT
9.1.3 OPERATING BUSINESS SEGMENTS
9.1.4 PRODUCT PORTFOLIO
9.1.5 BUSINESS PERFORMANCE
9.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.2.DHISTECH LTD.
9.2.1 COMPANY OVERVIEW
9.2.2 COMPANY SNAPSHOT
9.2.3 OPERATING BUSINESS SEGMENTS
9.2.4 PRODUCT PORTFOLIO
9.2.5 BUSINESS PERFORMANCE
9.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.3. GLENCOE SOFTWARE, INC.
9.3.1 COMPANY OVERVIEW
9.3.2 COMPANY SNAPSHOT
9.3.3 OPERATING BUSINESS SEGMENTS
9.3.4 PRODUCT PORTFOLIO
9.3.5 BUSINESS PERFORMANCE
9.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.4. HAMAMATSU PHOTONICS K.K.
9.4.1 COMPANY OVERVIEW
9.4.2 COMPANY SNAPSHOT
9.4.3 OPERATING BUSINESS SEGMENTS
9.4.4 PRODUCT PORTFOLIO
9.4.5 BUSINESS PERFORMANCE
9.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.5. INDICA LABS INC.
9.5.1 COMPANY OVERVIEW
9.5.2 COMPANY SNAPSHOT
9.5.3 OPERATING BUSINESS SEGMENTS
9.5.4 PRODUCT PORTFOLIO
9.5.5 BUSINESS PERFORMANCE
9.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.6. KONINKLIJKE PHILIPS N.V.
9.6.1 COMPANY OVERVIEW
9.6.2 COMPANY SNAPSHOT
9.6.3 OPERATING BUSINESS SEGMENTS
9.6.4 PRODUCT PORTFOLIO
9.6.5 BUSINESS PERFORMANCE
9.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.7. NIKON CORPORATION
9.7.1 COMPANY OVERVIEW
9.7.2 COMPANY SNAPSHOT
9.7.3 OPERATING BUSINESS SEGMENTS
9.7.4 PRODUCT PORTFOLIO
9.7.5 BUSINESS PERFORMANCE
9.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.8. PERKINELMER INC.
9.8.1 COMPANY OVERVIEW
9.8.2 COMPANY SNAPSHOT
9.8.3 OPERATING BUSINESS SEGMENTS
9.8.4 PRODUCT PORTFOLIO
9.8.5 BUSINESS PERFORMANCE
9.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.9. ROCHE (VENTANA MEDICAL SYSTEMS, INC.)
9.9.1 COMPANY OVERVIEW
9.9.2 COMPANY SNAPSHOT
9.9.3 OPERATING BUSINESS SEGMENTS
9.9.4 PRODUCT PORTFOLIO
9.9.5 BUSINESS PERFORMANCE
9.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.10. VISIOPHARM A/S
9.10.1 COMPANY OVERVIEW
9.10.2 COMPANY SNAPSHOT
9.10.3 OPERATING BUSINESS SEGMENTS
9.10.4 PRODUCT PORTFOLIO
9.10.5 BUSINESS PERFORMANCE
9.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT